Scalper1 News
Inovalon (INOV), a provider of Big Data services to health care payers, jumped 5% in early trading Friday on positive analyst coverage, continuing a rebound from a sharp slide. Goldman Sachs analyst Andre Benjamin upgraded Inovalon to buy from neutral with a price target of 31, saying that the valuation has become appealing. “The large addressable market should sustain strong growth for many years — $435 million in 2015E revenue implies 4% Scalper1 News
Scalper1 News